T he National Comprehensive Cancer Network (NCCN) started the roll-out of a new digital format designed to streamline access ...

The second trial, ASTX727-02, enrolled 133 patients with either MDS or CMML, including all French-American-British classification criteria and IPSS intermediate-1, intermediate-2, or high-risk ...

The NCCN Guidelines in Practice™ allows users to document every instance they access the guidelines while making care decisions for their patients. This frequently utilized activity, performed ...

"The recently updated NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric takes into account the latest published research and expert opinions from more ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene today announced a strategic agreement with the National Comprehensive Cancer Network® (NCCN®) to integrate its Clinical Practice Guidelines into the ...

These updates to the MDS NCCN Guidelines follow the U.S. Food and Drug Administration’s (FDA) approval in June 2024 of RYTELO (imetelstat) for the treatment of adult patients with low- to ...

NCCN intends to cover at least 90% of all incident childhood cancers through the growing library of NCCN Guidelines for pediatric cancers. The adult guidelines provide comprehensive management ...